InvestorsHub Logo
Followers 4
Posts 442
Boards Moderated 0
Alias Born 02/23/2021

Re: None

Monday, 05/16/2022 7:37:58 AM

Monday, May 16, 2022 7:37:58 AM

Post# of 9554
Food for thought or debate ...

All of the assets, transfers, etc have been outlined in the Financials for shareholders to review. Shareholders are choosing to undervalue the stock. HERB may claim the market unfairly valued the stock if there are any anti-competition claims filed.

We do not know the value of Equity Art because it has yet to be valued (I believe) and is off balance sheet. However, the ratio of the preferred shares 1:10 provides some direction of the value of Equity Art if you assume it is a reflection of the HERB Market Cap : Equity Art value

There should also be consideration for the transfer of GAAT to GY. At the time GAAT was valued at over 2.2B if allowing consideration for the Inventory, Property and Intangible value prior to the transfer. The transfer was supposedly a 1:1 (value for value) as described in the 2015 annual review. GY should be equal value to GAAT or shareholders need to be compensated for the difference if the assets were sold (I believe).

We also don't know the value that Beadswap (Crypto: BEAD) was sold for when BTZI acquired a 50% stake in 2021.